1. Houlihan WJ, Cooke G, Van Bochoven R, Perrine J, Takesue EI, Jukniewicz E.. (1982) Antiinflammatory properties of 8-aryl-5-isopropyl-2H-1,3-dioxolo[4,5-g]quinazolin-6(5H)-ones and -thiones., 25 (9): [PMID:7131493] [10.1021/jm00351a022] |
2. Reich MF, Johnson BD, Lenhard RH, Hanifin J. (1994) Derivatives of D-penicillamine as potential antiarthritic agents, 4 (9): [10.1016/S0960-894X(01)80249-3] |
3. Sharpe TR, Cherkofsky SC, Hewes WE, Smith DH, Gregory WA, Haber SB, Leadbetter MR, Whitney JG.. (1985) Preparation and antiarthritic and analgesic activity of 4,5-diaryl-2-(substituted thio)-1H-imidazoles and their sulfoxides and sulfones., 28 (9): [PMID:3875725] [10.1021/jm00147a011] |
4. Muchowski JM, Galeazzi E, Greenhouse R, Guzmán A, Peréz V, Ackerman N, Ballaron SA, Rovito JR, Tomolonis AJ, Young JM.. (1989) Synthesis and antiinflammatory and analgesic activity of 5-aroyl-6-(methylthio)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-ca rboxyl ic acids and 1-methyl-4-(methylthio)-5-aroylpyrrole-2-acetic acids., 32 (6): [PMID:2724294] [10.1021/jm00126a010] |
5. Maxwell JR, Wasdahl DA, Wolfson AC, Stenberg VI.. (1984) Synthesis of 5-aryl-2H-tetrazoles, 5-aryl-2H-tetrazole-2-acetic acids, and [(4-phenyl-5-aryl-4H-1,2,4-triazol-3-yl)thio]acetic acids as possible superoxide scavengers and antiinflammatory agents., 27 (12): [PMID:6094808] [10.1021/jm00378a007] |
6. Andrews PR, Craik DJ, Martin JL.. (1984) Functional group contributions to drug-receptor interactions., 27 (12): [PMID:6094812] [10.1021/jm00378a021] |
7. Schlegel DC, Zenitz BL, Fellows CA, Laskowski SC, Behn DC, Phillips DK, Botton I, Speight PT.. (1984) Bulky amine analogues of ketoprofen: potent antiinflammatory agents., 27 (12): [PMID:6502598] [10.1021/jm00378a027] |
8. Auzzi G, Bruni F, Cecchi L, Costanzo A, Vettori LP, Pirisino R, Corrias M, Ignesti G, Banchelli G, Raimondi L.. (1983) 2-Phenylpyrazolo[1,5-a]pyrimidin-7-ones. A new class of nonsteroidal antiinflammatory drugs devoid of ulcerogenic activity., 26 (12): [PMID:6606043] [10.1021/jm00366a009] |
9. Suomalainen P, Johans C, Söderlund T, Kinnunen PK.. (2004) Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability., 47 (7): [PMID:15027870] [10.1021/jm0309001] |
10. Zinnes H, Sircar JC, Lindo N, Schwartz ML, Fabian AC, Shavel J, Kasulanis CF, Genzer JD, Lutomski C, DiPasquale G.. (1982) Isoxicam and related 4-hydroxy-N-isoxazolyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxides. Potent nonsteroidal antiinflammatory agents., 25 (1): [PMID:7086815] [10.1021/jm00343a003] |
11. Yoshida F, Topliss JG.. (2000) QSAR model for drug human oral bioavailability., 43 (13): [PMID:10891117] [10.1021/jm0000564] |
12. Vigorita MG, Ottanà R, Monforte F, Maccari R, Trovato A, Monforte MT, Taviano MF.. (2001) Synthesis and antiinflammatory, analgesic activity of 3,3'-(1,2-ethanediyl)-bis[2-aryl-4-thiazolidinone] chiral compounds. Part 10., 11 (21): [PMID:11597401] [10.1016/s0960-894x(01)00476-0] |
13. Wilkerson WW, Copeland RA, Covington M, Trzaskos JM.. (1995) Antiinflammatory 4,5-diarylpyrroles. 2. Activity as a function of cyclooxygenase-2 inhibition., 38 (20): [PMID:7562922] [10.1021/jm00020a002] |
14. Lombardino JG.. (1981) Synthesis and antiinflammatory activity of metabolites of piroxicam., 24 (1): [PMID:7205872] [10.1021/jm00133a009] |
15. Vennerstrom JL, Holmes TJ.. (1987) Prostaglandin-H synthase inhibition by malonamides. Ring-opened analogues of phenylbutazone., 30 (2): [PMID:3100804] [10.1021/jm00385a031] |
16. Colmenarejo G, Alvarez-Pedraglio A, Lavandera JL.. (2001) Cheminformatic models to predict binding affinities to human serum albumin., 44 (25): [PMID:11728183] [10.1021/jm010960b] |
17. Ríos-Santamarina I, García-Domenech R, Gálvez J, Cortijo J, Santamaria P, Morcillo E.. (1998) New bronchodilators selected by molecular topology., 8 (5): [PMID:9871602] [10.1016/s0960-894x(98)00056-0] |
18. Lüllmann H, Timmermans PB, Weikert GM, Ziegler A.. (1980) Accumulation of drugs by guinea pig isolated atria. Quantitative correlations., 23 (5): [PMID:7381857] [10.1021/jm00179a017] |
19. Vennerstrom JL, Holmes TJ.. (1987) Preparation and evaluation of electrophilic derivatives of phenylbutazone as inhibitors of prostaglandin-H synthase., 30 (3): [PMID:3102742] [10.1021/jm00386a020] |
20. Powers LJ, Fogt SW, Ariyan ZS, Rippin DJ, Heilman RD, Matthews RJ.. (1981) Effect of structural change on acute toxicity and antiinflammatory activity in a series of imidazothiazoles and thiazolobenzimidazoles., 24 (5): [PMID:6972450] [10.1021/jm00137a022] |
21. Toja E, Selva D, Schiatti P.. (1984) 3-Alkyl-2-aryl-3H-naphth[1,2-d]imidazoles, a novel class of nonacidic antiinflammatory agents., 27 (5): [PMID:6609233] [10.1021/jm00371a010] |
22. Calcinari R, Case N, Guerrato A, Milanino R, Passarella E, Perchinunno M, Tamburini B, Sparatore F.. (1981) Synthesis and antiinflammatory activity of 2,2'-diaminobiphenyl derivatives., 24 (5): [PMID:7241523] [10.1021/jm00137a029] |
23. Meinke PT.. (2001) Perspectives in animal health: old targets and new opportunities., 44 (5): [PMID:11262075] [10.1021/jm990564h] |
24. Look GC, Schullek JR, Holmes CP, Chinn JP, Gordon EM, Gallop MA. (1996) The identification of cyclooxygenase-1 inhibitors from 4-thiazolidinone combinatorial libraries, 6 (6): [10.1016/0960-894X(96)00097-2] |
25. Tsukamoto G, Yoshino K, Kohno T, Ohtaka H, Kagaya H, Ito K.. (1980) Synthesis and antiinflammatory activity of some 2-(substituted-pyridinyl)benzimidazoles., 23 (7): [PMID:6772786] [10.1021/jm00181a007] |
26. Afzelius L, Zamora I, Masimirembwa CM, Karlén A, Andersson TB, Mecucci S, Baroni M, Cruciani G.. (2004) Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors., 47 (4): [PMID:14761192] [10.1021/jm030972s] |
27. Wilkerson WW, Galbraith W, Gans-Brangs K, Grubb M, Hewes WE, Jaffee B, Kenney JP, Kerr J, Wong N.. (1994) Antiinflammatory 4,5-diarylpyrroles: synthesis and QSAR., 37 (7): [PMID:8151626] [10.1021/jm00033a017] |
28. Khanum SA, D VT, Shashikanth S, Firdouse A.. (2004) Synthesis of some newer analogues of substituted dibenzoyl phenol as potent anti-inflammatory agents., 14 (21): [PMID:15454226] [10.1016/j.bmcl.2004.08.014] |
29. Hsu N, Cai D, Damodaran K, Gomez RF, Keck JG, Laborde E, Lum RT, Macke TJ, Martin G, Schow SR, Simon RJ, Villar HO, Wick MM, Beroza P.. (2004) Novel cyclooxygenase-1 inhibitors discovered using affinity fingerprints., 47 (20): [PMID:15369391] [10.1021/jm049950b] |
30. Kontogiorgis CA, Hadjipavlou-Litina DJ.. (2005) Synthesis and antiinflammatory activity of coumarin derivatives., 48 (20): [PMID:16190766] [10.1021/jm0580149] |
31. Mathew V, Keshavayya J, Vaidya VP, Giles D.. (2007) Studies on synthesis and pharmacological activities of 3,6-disubstituted-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and their dihydro analogues., 42 (6): [PMID:17331622] [10.1016/j.ejmech.2006.12.010] |
32. Venu TD, Shashikanth S, Khanum SA, Naveen S, Firdouse A, Sridhar MA, Shashidhara Prasad J.. (2007) Synthesis and crystallographic analysis of benzophenone derivatives--the potential anti-inflammatory agents., 15 (10): [PMID:17376692] [10.1016/j.bmc.2007.02.051] |
33. Kumar A, Rajput CS, Bhati SK.. (2007) Synthesis of 3-[4'-(p-chlorophenyl)-thiazol-2'-yl]-2-[(substituted azetidinone/thiazolidinone)-aminomethyl]-6-bromoquinazolin-4-ones as anti-inflammatory agent., 15 (8): [PMID:17317192] [10.1016/j.bmc.2007.01.042] |
34. Thorarensen A, Sarver RW, Tian F, Ho A, Romero DL, Marotti KR.. (2007) Human serum albumin binding assay based on displacement of a non selective fluorescent inhibitor., 17 (16): [PMID:17560104] [10.1016/j.bmcl.2007.05.077] |
35. Tanaka S, Tajima M, Tsukada M, Tabata M.. (1986) A comparative study on anti-inflammatory activities of the enantiomers, shikonin and alkannin., 49 (3): [PMID:3760886] [10.1021/np50045a014] |
36. Sondhi SM, Rani R, Roy P, Agrawal SK, Saxena AK.. (2009) Microwave-assisted synthesis of N-substituted cyclic imides and their evaluation for anticancer and anti-inflammatory activities., 19 (5): [PMID:19201604] [10.1016/j.bmcl.2008.07.048] |
37. Kumar A, Rajput CS.. (2009) Synthesis and anti-inflammatory activity of newer quinazolin-4-one derivatives., 44 (1): [PMID:18501478] [10.1016/j.ejmech.2008.03.018] |
38. Máñez S, Recio MC, Gil I, Gómez C, Giner RM, Waterman PG, Ríos JL.. (1999) A glycosyl analogue of diacylglycerol and other antiinflammatory constituents from Inula viscosa., 62 (4): [PMID:10217718] [10.1021/np980132u] |
39. Khanum SA, Girish V, Suparshwa SS, Khanum NF.. (2009) Benzophenone-N-ethyl piperidine ether analogues--synthesis and efficacy as anti-inflammatory agent., 19 (7): [PMID:19272777] [10.1016/j.bmcl.2009.02.070] |
40. Fourie TG, Snyckers FO.. (1984) A flavone with antiinflammatory activity from the roots of Rhus undulata., 47 (6): [PMID:6241941] [10.1021/np50036a037] |
41. Alcaraz MJ, Jimenez MJ, Valverde S, Sanz J, Rabanal RM, Villar A.. (1989) Anti-inflammatory compounds from Sideritis javalambrensis n-hexane extract., 52 (5): [PMID:2481715] [10.1021/np50065a027] |
42. Fourie TG, Snyckers FO.. (1989) A pentacyclic triterpene with anti-inflammatory and analgesic activity from the roots of Commiphora merkeri., 52 (5): [PMID:2607349] [10.1021/np50065a034] |
43. Sharma DK, Hall IH.. (1991) Hypolipidemic, anti-inflammatory, and antineoplastic activity and cytotoxicity of flavonolignans isolated from Hydnocarpus wightiana seeds., 54 (5): [PMID:1800632] [10.1021/np50077a010] |
44. Venu TD, Khanum SA, Firdouse A, Manuprasad BK, Shashikanth S, Mohamed R, Vishwanth BS.. (2008) Synthesis and anti-inflammatory activity of 2-(2-aroylaroxy)-4,6-dimethoxy pyrimidines., 18 (15): [PMID:18621525] [10.1016/j.bmcl.2008.06.061] |
45. Verma A, Saraf SK.. (2008) 4-thiazolidinone--a biologically active scaffold., 43 (5): [PMID:17870209] [10.1016/j.ejmech.2007.07.017] |
46. Singh N, Bhati SK, Kumar A.. (2008) Thiazolyl/oxazolyl formazanyl indoles as potent anti-inflammatory agents., 43 (11): [PMID:18289736] [10.1016/j.ejmech.2007.12.024] |
47. Sondhi SM, Dinodia M, Jain S, Kumar A.. (2008) Synthesis of biologically active N-methyl derivatives of amidines and cyclized five-membered products of amidines with oxalyl chloride., 43 (12): [PMID:18022734] [10.1016/j.ejmech.2007.10.005] |
48. Bhati SK, Kumar A.. (2008) Synthesis of new substituted azetidinoyl and thiazolidinoyl-1,3,4-thiadiazino (6,5-b) indoles as promising anti-inflammatory agents., 43 (11): [PMID:18063224] [10.1016/j.ejmech.2007.10.012] |
49. Abad MJ, Bermejo P, Villar A, Valverde S.. (1993) Anti-inflammatory activity of two flavonoids from Tanacetum microphyllum., 56 (7): [PMID:8377020] [10.1021/np50097a022] |
50. Khanum SA, Khanum NF, Shashikanth M.. (2008) Synthesis and anti-inflammatory activity of 2-aryloxy methyl oxazolines., 18 (16): [PMID:18662873] [10.1016/j.bmcl.2008.07.029] |
51. Chandra T, Garg N, Lata S, Saxena KK, Kumar A.. (2010) Synthesis of substituted acridinyl pyrazoline derivatives and their evaluation for anti-inflammatory activity., 45 (5): [PMID:20149499] [10.1016/j.ejmech.2010.01.009] |
52. Prado-Prado FJ, García-Mera X, González-Díaz H.. (2010) Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species., 18 (6): [PMID:20185316] [10.1016/j.bmc.2010.01.068] |
53. Gozalbes R, Pineda-Lucena A.. (2010) QSAR-based solubility model for drug-like compounds., 18 (19): [PMID:20810286] [10.1016/j.bmc.2010.08.003] |
54. Diamandis P, Wildenhain J, Clarke ID, Sacher AG, Graham J, Bellows DS, Ling EK, Ward RJ, Jamieson LG, Tyers M, Dirks PB.. (2007) Chemical genetics reveals a complex functional ground state of neural stem cells., 3 (5): [PMID:17417631] [10.1038/nchembio873] |
55. Yuan J, Johnson RL, Huang R, Wichterman J, Jiang H, Hayton K, Fidock DA, Wellems TE, Inglese J, Austin CP, Su XZ.. (2009) Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum., 5 (10): [PMID:19734910] [10.1038/nchembio.215] |
56. PubChem BioAssay data set, |
57. PubChem BioAssay data set, |
58. PubChem BioAssay data set, |
59. PubChem BioAssay data set, |
60. PubChem BioAssay data set, |
61. PubChem BioAssay data set, |
62. PubChem BioAssay data set, |
63. Greene N, Fisk L, Naven RT, Note RR, Patel ML, Pelletier DJ.. (2010) Developing structure-activity relationships for the prediction of hepatotoxicity., 23 (7): [PMID:20553011] [10.1021/tx1000865] |
64. Ekins S, Williams AJ, Xu JJ.. (2010) A predictive ligand-based Bayesian model for human drug-induced liver injury., 38 (12): [PMID:20843939] [10.1124/dmd.110.035113] |
65. Fourches D, Barnes JC, Day NC, Bradley P, Reed JZ, Tropsha A.. (2010) Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species., 23 (1): [PMID:20014752] [10.1021/tx900326k] |
66. Unpublished dataset, |
67. Bartalis J, Halaweish FT.. (2011) In vitro and QSAR studies of cucurbitacins on HepG2 and HSC-T6 liver cell lines., 19 (8): [PMID:21459003] [10.1016/j.bmc.2011.01.037] |
68. Buttar D, Colclough N, Gerhardt S, MacFaul PA, Phillips SD, Plowright A, Whittamore P, Tam K, Maskos K, Steinbacher S, Steuber H.. (2010) A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactions., 18 (21): [PMID:20869876] [10.1016/j.bmc.2010.08.052] |
69. PubChem BioAssay data set, |
70. PubChem BioAssay data set, |
71. PubChem BioAssay data set, |
72. PubChem BioAssay data set, |
73. Tukey RH, Strassburg CP.. (2000) Human UDP-glucuronosyltransferases: metabolism, expression, and disease., 40 (1): [PMID:10836148] [10.1146/annurev.pharmtox.40.1.581] |
74. Kiang TK, Ensom MH, Chang TK.. (2005) UDP-glucuronosyltransferases and clinical drug-drug interactions., 106 (1): [PMID:15781124] [10.1016/j.pharmthera.2004.10.013] |
75. Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program. DrugMatrix in vitro pharmacology data, |
76. Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W.. (2011) Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps)., 7 (12): [PMID:22194678] [10.1371/journal.pcbi.1002310] |
77. Honey, Thareja S, Kumar M, Sinha VR.. (2012) Self-organizing molecular field analysis of NSAIDs: assessment of pharmacokinetic and physicochemical properties using 3D-QSPkR approach., 53 [PMID:22521372] [10.1016/j.ejmech.2012.03.037] |
78. Sakatis MZ, Reese MJ, Harrell AW, Taylor MA, Baines IA, Chen L, Bloomer JC, Yang EY, Ellens HM, Ambroso JL, Lovatt CA, Ayrton AD, Clarke SE.. (2012) Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds., 25 (10): [PMID:22931300] [10.1021/tx300075j] |
79. Takeda M, Khamdang S, Narikawa S, Kimura H, Hosoyamada M, Cha SH, Sekine T, Endou H.. (2002) Characterization of methotrexate transport and its drug interactions with human organic anion transporters., 302 (1): [PMID:12130730] [10.1124/jpet.102.034330] |
80. Apiwattanakul N, Sekine T, Chairoungdua A, Kanai Y, Nakajima N, Sophasan S, Endou H.. (1999) Transport properties of nonsteroidal anti-inflammatory drugs by organic anion transporter 1 expressed in Xenopus laevis oocytes., 55 (1): [PMID:10220563] |
81. Uwai Y, Saito H, Inui K.. (2000) Interaction between methotrexate and nonsteroidal anti-inflammatory drugs in organic anion transporter., 409 (1): [PMID:11099697] [10.1016/s0014-2999(00)00837-2] |
82. Masuda S, Saito H, Inui KI.. (1997) Interactions of nonsteroidal anti-inflammatory drugs with rat renal organic anion transporter, OAT-K1., 283 (1): [PMID:9399974] |
83. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
84. Karlgren M, Vildhede A, Norinder U, Wisniewski JR, Kimoto E, Lai Y, Haglund U, Artursson P.. (2012) Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions., 55 (10): [PMID:22541068] [10.1021/jm300212s] |
85. Alam O, Khan SA, Siddiqui N, Ahsan W. (2010) Synthesis and pharmacological evaluation of newer thiazolo [3,2-a] pyrimidines for anti-inflammatory and antinociceptive activity, 19 (9): [10.1007/s00044-009-9267-8] |
86. PubChem BioAssay data set, |
87. Ragab FA, Abdel Gawad NM, Georgey HH, Said MF.. (2013) Synthesis of novel 1,3,4-trisubstituted pyrazoles as anti-inflammatory and analgesic agents., 63 [PMID:23567953] [10.1016/j.ejmech.2013.03.005] |
88. Lal J, Gupta SK, Thavaselvam D, Agarwal DD.. (2013) Biological activity, design, synthesis and structure activity relationship of some novel derivatives of curcumin containing sulfonamides., 64 [PMID:23685942] [10.1016/j.ejmech.2013.03.012] |
89. Unpublished dataset, |
90. Unpublished dataset, |
91. Unpublished dataset, |
92. De Bruyn T, van Westen GJ, Ijzerman AP, Stieger B, de Witte P, Augustijns PF, Annaert PP.. (2013) Structure-based identification of OATP1B1/3 inhibitors., 83 (6): [PMID:23571415] [10.1124/mol.112.084152] |
93. Biour M, Ben Salem C, Chazouillères O, Grangé JD, Serfaty L, Poupon R.. (2004) [Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs]., 28 (8-9): [PMID:15646539] [10.1016/s0399-8320(04)95062-2] |
94. PubChem BioAssay data set, |
95. PubChem BioAssay data set, |
96. PubChem BioAssay data set, |
97. PubChem BioAssay data set, |
98. Krapcho J, Turk CF.. (1979) Bicyclic pyrazolines, potential central nervous system depressants and antiinflammatory agents., 22 (2): [PMID:423202] [10.1021/jm00188a018] |
99. Takaya M, Sato M, Terashima K, Tanizawa H, Maki Y.. (1979) A new nonsteroidal analgesic-antiinflammatory agent. Synthesis and activity of 4-ethoxy-2-methyl-5-morpholino-3(2H)-pyridazinone and related compounds., 22 (1): [PMID:311385] [10.1021/jm00187a013] |
100. Nagakura M, Ota T, Shimidzu N, Kawamura K, Eto Y, Wada Y.. (1979) Syntheses and antiinflammatory actions of 4,5,6,7-tetrahydroindazole-5-carboxylic acids., 22 (1): [PMID:423183] [10.1021/jm00187a012] |
101. Kaltenbronn JS.. (1977) Antiinflammatory activity of isomeric phenylnaphthaleneacetic acids., 20 (4): [PMID:850248] [10.1021/jm00214a033] |
102. Clark RL, Pessolano AA, Witzel B, Lanza T, Shen TY, Van Arman CG, Risley EA.. (1978) 2-(Substituted phenyl)oxazolo[4,5-b]pyridines and 2-(substituted phenyl)oxazolo[5,4-b]pyridines as nonacidic antiinflammatory agents., 21 (11): [PMID:102794] [10.1021/jm00209a014] |
103. Clark RL, Pessolano AA, Shen TY, Jacobus DP, Jones H, Lotti VJ, Flataker LM.. (1978) Synthesis and analgesic activity of 1,3-dihydro-3-(substituted phenyl)imidazo[4,5-b]pyridin-2-ones and 3-(substituted phenyl)-1,2,3-triazolo[4,5-b]pyridines., 21 (9): [PMID:309950] [10.1021/jm00207a023] |
104. Dunwell DW, Evans D.. (1977) Synthesis and antiinflammatory activity of some 2-aryl-6-benzoxazoleacetic acid derivatives., 20 (6): [PMID:874954] [10.1021/jm00216a011] |
105. Sprague PW, Heikes JE.. (1977) Synthesis and antiinflammatory activity of cis-4,5,6,7,8,8a,9-hexahydro-alpha-methyl-5H-fluorene-2-acetic acid., 20 (5): [PMID:140243] [10.1021/jm00215a023] |
106. Cohen N, Banner BL, Lopresti RJ.. (1978) Analgesic activity of novel spiro heterocycles. 2-Amino-7-oxa-3-thia-1-azaspiro[5,5]undec-1-enes and related compounds., 21 (9): [PMID:722756] [10.1021/jm00207a011] |
107. Heilman WP, Battershell RD, Pyne WJ, Goble PH, Magee TA.. (1978) Synthesis and antiinflammatory evaluation of substituted isophthalonitriles, trimesonitriles, benzonitriles, and terephthalonitriles., 21 (9): [PMID:722757] [10.1021/jm00207a013] |
108. Welstead WJ, Moran HW, Stauffer HF, Turnbull LB, Sancilio LF.. (1979) Antiinflammatory agents. 1. Synthesis and antiinflammatory activity of 2-amino-3-benzoylphenylacetic acid., 22 (9): [PMID:490552] [10.1021/jm00195a012] |
109. Walsh DA, Sancilio LF, Reese DL.. (1978) Aroyl- and arylisoquinolineacetic acids as antiinflammatory agents., 21 (6): [PMID:671456] [10.1021/jm00204a015] |
110. Bennett GB, Mason RB, Alden LJ, Roach JB.. (1978) Synthesis and antiinflammatory activity of trisubstituted pyrimidines and triazines., 21 (7): [PMID:671461] [10.1021/jm00205a006] |
111. Hicks TA, Smith CE, Williamson WR, Day EH.. (1979) Potential antiinflammatory compounds. 1. Antiinflammatory phenylpiperidine derivatives., 22 (12): [PMID:536991] [10.1021/jm00198a006] |
112. Smith CE, Williamson WR, Cashin CH, Kitchen EA.. (1979) Potential antiinflammatory compounds. 3. Compounds derived from acenaphthene and indan., 22 (12): [PMID:536992] [10.1021/jm00198a007] |
113. Hirose N, Kuriyama S, Kato Y, Toyoshima S.. (1976) Antiinflammatory activity of some 2,3-dihydrobenzofuran-5-acetic acids and related compounds., 19 (2): [PMID:1249810] [10.1021/jm00224a020] |
114. van Dijk J, Zwagemakers JM.. (1977) Oxime ether derivatives, a new class of nonsteroidal antiinflammatory compounds., 20 (9): [PMID:926121] [10.1021/jm00219a018] |
115. Evans D, Smith CE, Williamson WR.. (1977) Synthesis and antiinflammatory activity of some 2-substituted 4- and 7-benzoxazoleacetic and alpha-methylacetic acids., 20 (1): [PMID:833819] [10.1021/jm00211a039] |
116. Ueno K, Kubo S, Tagawa H, Yoshioka T, Tsukada W.. (1976) 6,11-Dihydro-11-oxodibenz [b,e] oxepinacetic acids with potent antiinflammatory activity., 19 (7): [PMID:940112] [10.1021/jm00229a017] |
117. Martel RR, Demerson CA, Humber LG, Philipp AH.. (1976) Etodolic acid and related compounds. Chemistry and antiinflammatory actions of some potent di- and trisubstituted 1, 3, 4, 9-tetrahydropyrano[3, 4-b]indole-1-acetic acids., 19 (3): [PMID:1255663] [10.1021/jm00225a010] |
118. Sugiura S, Ohno S, Ohtani O, Izumi K, Kitamikado T, Asai H, Kato K.. (1977) Synthesis and antiinflammatory and hypnotic activity of 5-alkoxy-3-(N-substituted carbamoyl)-1-phenylpyrazoles., 20 (1): [PMID:833830] [10.1021/jm00211a016] |
119. Asselin AA, Humber LG, Dobson TA, Komlossy J.. (1976) Cycloalkanoindoles. 1. Syntheses and antiinflammatory actions of some acidic tetrahydrocarbazoles, cyclopentindoles, and cycloheptindoles., 19 (6): [PMID:950647] [10.1021/jm00228a010] |
120. Brannigan LH, Hodge RB, Field L.. (1976) Biologically oriented organic sulfur chemistry. 14. Antiinflammatory properties of some aryl sulfides, sulfoxides, and sulfones., 19 (6): [PMID:950649] [10.1021/jm00228a012] |
121. Scherrer RA, Howard SM.. (1977) Use of distribution coefficients in quantitative structure-activity relationships., 20 (1): [PMID:13215] [10.1021/jm00211a010] |
122. Buckler RT, Hartzler HE, Kurchacova E, Nichols G, Phillips BM.. (1978) Synthesis and antiinflammatory activity of some 1,2,3- and 1,2,4-triazolepropionic acids., 21 (12): [PMID:722733] [10.1021/jm00210a015] |
123. Mark Wenlock and Nicholas Tomkinson. Experimental in vitro DMPK and physicochemical data on a set of publicly disclosed compounds, [10.6019/CHEMBL3301361] |
124. Drug metabolism data, |
125. Unpublished dataset, |
126. WHO Anatomical Therapeutic Chemical Classification, |
127. British National Formulary (72nd edition), |
128. Open TG-GATES, [10.6019/CHEMBL3885861] |
129. DrugMatrix, [10.6019/CHEMBL3885881] |
130. Franck Touret, Magali Gilles, Karine Barral, Antoine Nougairède, Etienne Decroly, Xavier de Lamballerie, Bruno Coutard. (2020) In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication, [10.1101/2020.04.03.023846] |
131. Bernhard Ellinger, Denisa Bojkova, Andrea Zaliani, Jindrich Cinatl, Carsten Claussen, Sandra Westhaus, Jeanette Reinshagen, Maria Kuzikov, Markus Wolf, Gerd Geisslinger, Philip Gribbon, Sandra Ciesek. (2020) Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection, [10.21203/rs.3.rs-23951/v1] |
132. Dargó G, Bajusz D, Simon K, Müller J, Balogh GT.. (2020) Human Serum Albumin Binding in a Vial: A Novel UV-pH Titration Method To Assist Drug Design., 63 (4): [PMID:31995375] [10.1021/acs.jmedchem.0c00046] |
133. (2017) Sensitization of cancer cells to nampt inhibitors by nicotinic acid phosphoribosyltransferase neutralization, |
134. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani. (2020) Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen, [10.6019/CHEMBL4495564] |
135. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen. (2020) Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort, [10.6019/CHEMBL4495565] |
136. Ellen Van Damme. (2021) Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity, [10.6019/CHEMBL4651402] |
137. Bernhard Ellinger, Justus Dick, Vanessa Lage-Rupprecht, Bruce Schultz, Andrea Zaliani, Marcin Namysl, Stephan Gebel, Ole Pless, Jeanette Reinshagen, Christian Ebeling, Alexander Esser, Marc Jacobs, Carsten Claussen, and Martin Hofmann-Apitius. (2021) HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators, [10.6019/CHEMBL4808148] |
138. Alagarsamy V, Chitra K, Saravanan G, Solomon VR, Sulthana MT, Narendhar B.. (2018) An overview of quinazolines: Pharmacological significance and recent developments., 151 [PMID:29656203] [10.1016/j.ejmech.2018.03.076] |
139. Sutherland JJ, Yonchev D, Fekete A, Urban L.. (2023) A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs., 14 (1): [PMID:37468498] [10.1038/s41467-023-40064-9] |
140. Unpublished dataset, |